StoneMill Pharma
StoneMill Pharma
StoneMill Pharma

Tag: latent TB screening

blg-img3-1.jpg
Dec 16, 2025
  • Miranda Rathbone
  • 10

TNF Inhibitors and TB Reactivation: Screening and Monitoring Guidelines 2025

TNF inhibitors help treat autoimmune diseases but carry a risk of reactivating latent tuberculosis. Learn how screening, drug choices, and monitoring can prevent life-threatening TB cases in 2025.

Recent Posts

Zidovudine and How Pharmaceutical Companies Shaped HIV Treatment
Nov 18, 2025
Zidovudine and How Pharmaceutical Companies Shaped HIV Treatment
Neoadjuvant vs. Adjuvant Therapy: What You Need to Know About Treatment Sequencing
Feb 25, 2026
Neoadjuvant vs. Adjuvant Therapy: What You Need to Know About Treatment Sequencing
Clozapine and Smoking: How CYP1A2 Induction Affects Dose Needs and Safety
Feb 18, 2026
Clozapine and Smoking: How CYP1A2 Induction Affects Dose Needs and Safety
OTC Topical Pain Relievers: Creams, Gels, and Patches Safety Guide
Jan 21, 2026
OTC Topical Pain Relievers: Creams, Gels, and Patches Safety Guide
Immunosuppressants and Cancer History: What You Need to Know About Recurrence Risk
Jan 1, 2026
Immunosuppressants and Cancer History: What You Need to Know About Recurrence Risk

Categories

  • Health (223)
  • Lifestyle (3)
  • Technology (1)

Archives

  • August 2026 (6)
  • July 2026 (15)
  • June 2026 (12)
  • May 2026 (12)
  • April 2026 (14)
  • March 2026 (13)
  • February 2026 (14)
  • January 2026 (26)
  • December 2025 (26)
  • November 2025 (22)
  • October 2025 (27)
  • September 2025 (14)
StoneMill Pharma
  • About
  • Terms of Service
  • Privacy Policy
  • Data Protection Rights
  • Contact

© 2026. All rights reserved.